Buying unpopular companies when their share prices have been demolished is a time-honored strategy that can generate market-beating returns for the patient. Even so, I’m not keen on the following 3 beaten-up businesses. Here’s why:
Brambles Limited (ASX: BXB)
Brambles has had a tough year, with shares diving 20% following a first quarter downgrade and weak first half. While sales have picked up somewhat in the 3rd quarter, the business remains under pressure from competition. Additionally, management recently withdrew their target of 20% Returns on Capital Invested (ROCI) by 2019, seemingly satisfied with today’s levels of ~15.9% (or 14.8%, under their previous methodology). This suggests that the business itself is not capable of generating higher returns on its existing assets, and will only grow via expansion.
There is a price at which I’d buy Brambles shares, but $9.94 is not it.
Quintis Ltd (ASX: QIN)
Shares in sandalwood grower-turned pharmaceutical company Quintis, formerly TFS Corporation, have dived this year after short seller Glaucus Capital asserted that the company was a Ponzi-like scheme. The seriousness of these allegations was accentuated by the subsequent sudden departure of the managing director, Frank Wilson, who ‘received an offer to potentially partner with an unnamed international corporation to present a proposed change of control transaction to the Company board.’
Foolish readers have seen this before with Surfstitch Group Ltd (ASX: SRF). Different company, different situation, but Mr Wilson’s departure is still a big red flag in my opinion. It is also important to remember that Glaucus stands to profit from a decline in Quintis’ shares, so they are incentivised to spook shareholders. Either way I would not feel comfortable touching this one without serious investigation.
Wellard Ltd (ASX: WLD)
Wellard is a live animal exporter and meat processing company that has been smashed by high cattle prices and restructuring, resulting in ballooning debt and weak cash flow. Management recently announced a $52 million capital raising, fortunately with shares to institutions issued at $0.24 each, above recent market prices. This will dilute existing owners significantly, given the company has a market capitalisation of $100 million or so at present. I think there is an opportunity to find value in Wellard, which had net tangible assets of $0.42 per share as at 31 December 2016 (pre- capital raising) and could prove very cheap if it is able to return to profitability and sustainable cash generation.
However, the company’s net debt of $188 million is very high and the recent capital raising diluted the value of each share significantly, making them less valuable if the company returns to profitability. I’m interested, but think it is probably too risky for me.
Read on to discover 3 high quality businesses that are a much better opportunity than Brambles, Quintis, and Wellard, in my opinion:
For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
If you’re expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you’ll be sorely disappointed. Not only are their dividends growing at a snail’s pace, their profits are under pressure too due to the increasing competitive environment.
The contrast to these “new breed” blue chips couldn’t be greater… especially the very real prospect of significant share price gains, something that’s looking less likely from the usual blue chip suspects.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.